from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0041/leuS

LFCtreatmentdescriptionclass of inhibitor

-1.668

Amikacinug/mL Amikacintranslation

-1.546

Cap5-10ug/mL Capreomycintranslation

-2.611

Rox10-50 ug/mL Roxithromycintranslation

-0.466

SM2-5 ug/mL Streptomycintranslation

-3.175

Tet5-10 ug/mL Tetracyclinetranslation

-0.374

Rif0.2-5ug/mL Rifampicintranscription

-0.256

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.413

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.630

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.826

CPZ10-50 ug/mL Chlorpromazinerespiration

0.290

Clofazimine10-13 ug/mL Clofaziminerespiration

0.900

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.977

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.223

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.604

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.867

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.777

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

1.189

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.577

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.353

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.146

KCN5-20 ug/mL Potassium cyaniderespiration

0.842

NaN30.2-2 mM Sodium aziderespiration

0.695

Nigericin50 uM Nigericinrespiration

-0.591

TRC10-150 ug/mL Triclosanrespiration

0.211

TRZ10-25 ug/mL Thioridazinerespiration

0.088

Valinomycin0.5-10 uM Valinomycinrespiration

2.024

ZnSO42 mM ZnSO4respiration

0.117

menadione6-10 ug/mL Menadionerespiration

-0.061

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.491

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.337

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.887

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.223

NRP_1Non-replicating persistence stage 1dosRassociated

0.439

Amp0.2mg/mL AmpicillincellWall

0.416

Cephalexin20-100 ug/mL CephalexincellWall

0.629

Cerulenin0.32-5 ug/mL CerulenincellWall

0.439

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.065

EMB10-20 ug/mL EthambutolcellWall

0.629

Eta12-40 ug/mL EthionamidecellWall

1.026

INH0.2-0.4 ug/mL IsoniazidcellWall

0.593

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.276

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.465

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.613

BZA0.12 mg/mL BenzamidearomaticAmides

-0.040

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.089

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.797

H2O24 mM hydrogen peroxideDNAdamaging

-0.277

Levo10 ug/mL LevofloxacinDNAdamaging

0.251

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.578

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.078

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.008

UVUV-irradiationDNAdamaging

-1.296

ARP41-4 ug/mL Antitubercular compound ARP4?

0.525

Antimycin12.5-50 ug/mL Antimycin A?

0.597

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.559

PA_110-50 ug/mL Antitubercular compound PA-1?

0.796

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.743

PA8240.2-2 ug/mL PA-824?

-1.185

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.392

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.490

Verapamil50 uM Verapamil?

0.363

mercaptoethanol2 mM 2-Mercaptoethanol?

0.720

methoxatin10-20 ug/mL Methoxatin?